Immunological mechanism and correspondent antigen of anti PD-1/PD-L1 antibody Related lung adverse events
Not Applicable
Recruiting
- Conditions
- non-small-cell lung cancer
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
1. Patients who have judged that their participation in this study is inappropriate
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To elucidate the responsible T cell fraction of onset pulmonary adverse events by anti PD-1 / PD-L1 antibody therapy
- Secondary Outcome Measures
Name Time Method